The Last Clinic Visit Conducted in Promore Pharma’s Phase II Study of Ensereptide

3 years ago

STOCKHOLM, SE / ACCESSWIRE / June 13, 2022 / Promore Pharma (STO:PROMO) (FRA:8T0)STOCKHOLM, 13 June 2022 - Promore Pharma AB…

Jaguar Health Announces Publication of Onco’Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients

3 years ago

Diarrhea is also a prevalent side effect in dogs undergoing cancer treatment; managing diarrhea can be important to maintain successful…

Aytu BioPharma to Participate in the Lytham Partners Summer 2022 Investor Conference

3 years ago

ENGLEWOOD, CO / ACCESSWIRE / June 13, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and…

Poko Innovations Qualify As Finalists Across Multiple Award Categories At World CBD Awards

3 years ago

Cannmed announced as a finalist at the World CBD Awards for Best CBD White Label BrandCanndid announced as a finalist…

Empower Clinics Revenues Increase Substantially

3 years ago

3,000 Tests and appointments completed since June 1st add to increased revenue across divisionsVANCOUVER, BC / ACCESSWIRE / June 13,…

cbdMD, Inc. CEO Steps Down

3 years ago

Martin Sumichrast resigns as CEO, Board MemberCharlotte, North Carolina--(Newsfile Corp. - June 13, 2022) - cbdMD, Inc. (NYSE American: YCBD)…

CENTR Brands Corp Announces Arjan Chima as New Chief Executive Officer

3 years ago

Founder and current CEO Joseph E. Meehan will assume new role as CENTR's Founder and Board Chairman. Founder and current…

Innovaccer Named to AVIA Connect’s Top 50 Companies in Remote Patient Monitoring Report

3 years ago

Innovaccer’s remote patient monitoring has been recognized by AVIA Connect for its role in advancing virtual acute care solutions to…

LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System

3 years ago

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced femtosecond laser…

Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil

3 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / June 13, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to…